Responses
Oral Presentations
Abstract session: RA therapy beyond TNF inhibition
OP0044 Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in RA: Two Year Results from the Ample Study
Compose a Response to This Article
Other responses
No responses have been published for this article.